KEAP1 and non-small cell lung carcinoma: As a result, ML385 induced selective toxicity in both A549 and H460 NSCLC cells harboring KEAP1 mutations, enhancing the cytotoxic effects of Doxorubicin, Carboplatin and Paclitaxel without affecting the non-tumorigenic BEAS2B cells.